Replies to post #243453 on NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

Date on the news wire is August 7th 2019 so definitely not 3 year old news Ick.

Cognate is a results-driven contract development and manufacturing organization (CDMO) specializing in cell and cell-mediated gene therapy products. Since 2002, Cognate has serviced autologous and allogeneic products in various stages of development from preclinical to Phase 3, and most recently in pivotal Phase 3 with FDA pre-approval inspection preparation. With development and manufacturing at our core,